Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

NCT05895279 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05895279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
August 2, 2021
Completion date
October 1, 2021
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma